Concepedia

Publication | Open Access

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

1K

Citations

41

References

2009

Year

Abstract

The addition of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer. (ClinicalTrials.gov number, NCT00295646.)

References

YearCitations

Page 1